Neurofit (380550) has 4 disclosed insider purchases and 0 disclosed disposals on record, filed by 2 distinct insiders. Together those filings cover ₩43M ($30K) in reported transaction value. The earliest filing StockDrifts holds for Neurofit is dated 2025-07-25; the most recent is 2026-05-29. All of it is parsed from DART D001/D002 insider disclosures, the official disclosure system operated by the Financial Supervisory Service (Korea). Across these filings the average return since disclosure is -8.56%, measured from each filing date to the latest available close.
| Date | Type | Source | Insider | Position | Shares | Price at filing | Return | Value |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | BUY | Market Buy | 빈준길 Binjungil | Co-CEO | 762 | ₩14,480 | -8.6% | ₩11M ($8K) |
| 2026-05-29 | BUY | Market Buy | 김동현 Donghyun Kim | Co-CEO | 1.0K | ₩14,480 | -8.6% | ₩14M ($10K) |
| 2026-05-29 | BUY | Market Buy | 빈준길 Binjungil | Co-CEO | 238 | ₩14,480 | -8.6% | ₩3M ($2K) |
| 2026-05-29 | BUY | Market Buy | 빈준길 Binjungil | Co-CEO | 1.0K | ₩14,480 | -8.6% | ₩14M ($10K) |
| 2026-04-30 | BUY | 주식매수선택권 | 김창일 Kim Chang-il | vice president | 21.3K | ₩20,100 | +0.0% | ₩428M ($297K) |
| 2025-10-17 | BUY | 주식매수선택권 | 임현국 Lim Hyeon-guk | Managing Director | 29.6K | ₩21,000 | +39.3% | ₩622M ($432K) |
| 2025-10-17 | BUY | 주식매수선택권 | 임현국 Lim Hyeon-guk | Managing Director | 14.6K | ₩21,000 | +39.3% | ₩307M ($214K) |
| 2025-08-12 | BUY | 주식매수선택권 | 임현국 Lim Hyeon-guk | Managing Director | 15.0K | ₩14,990 | +95.1% | ₩225M ($156K) |
| 2025-07-25 | BUY | 신규상장 | 빈준길 Binjungil | Co-CEO | 1.2M | ₩20,300 | +44.1% | ₩24.1B ($16.7M) |
| 2025-07-25 | BUY | 신규상장 | 김동현 Donghyun Kim | Co-CEO | 1.8M | ₩20,300 | +44.1% | ₩36.1B ($25.1M) |
Every trade listed above is disclosed in DART D001/D002 insider disclosures, filed with the Financial Supervisory Service (Korea). View the original DART filings for Neurofit. For how StockDrifts scores these disclosures, see the Korea insider signal tier research, or browse every Korean stock we track.